British Journal of Pharmacology

The British Journal of Pharmacology is a biweekly peer-reviewed medical journal covering all aspects of experimental pharmacology. It is published for the British Pharmacological Society by Wiley-Blackwell. According to the Journal Citation Reports, its 2009 impact factor is 5.204 ranking it 19th in the category "Pharmacology & Pharmacy". The journal publishes Research Papers, Review Articles, Commentaries and Correspondence in all fields of pharmacology. It also publishes themed issues, as well as supplements, including the Guide to Receptors and Channels. The current editor in chief is J.C. McGrath. Previous editors in chief include Humphrey Rang, Alan North, Phil Moore, Bill Large, and Tony Birmingham. A sister journal, also published for the British Pharmacological Society by Wiley-Blackwell is the British Journal of Clinical Pharmacology.

Publisher
Wiley-Blackwell
Country
United Kingdom
History
1968–present
Website
http://www.brjpharmacol.org/
Impact factor
5.204 (2009)

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Treatment of chloroquine poisoning

Research by Bangor University's Professor Dyfrig Hughes has provided important evidence on the safety of treatments that are being tested for use in COVID-19.

Immunology

Bee venom may help treat eczema

Bee venom and its major component, melittin, may be effective treatments for atopic dermatitis (or eczema), according to a British Journal of Pharmacology study.

Diseases, Conditions, Syndromes

The latest on chronic fatigue syndrome

(HealthDay)—Illnesses that lack exact testing methods can be difficult to diagnose, treat and live with, both physically and emotionally. Chronic fatigue syndrome, or CFS, is one such disease. Until recently, it was very ...

page 1 from 7